DRREDDY's weekly return of -1.47% was relatively better than its peers, with a lower volatility of 9.79%. The stock's Sharpe ratio of -0.80 indicates a poor risk-adjusted return. Compared to its peers, DRREDDY outperformed SUNPHARMA and HINDUNILVR, but underperformed DIVISLAB. Overall, the stock's risk profile was moderate this week.

[Volatility: 9.79%]